These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12941791)

  • 1. Intracellular visualization of prostate cancer using magnetic resonance imaging.
    Heckl S; Pipkorn R; Waldeck W; Spring H; Jenne J; von der Lieth CW; Corban-Wilhelm H; Debus J; Braun K
    Cancer Res; 2003 Aug; 63(16):4766-72. PubMed ID: 12941791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNN-Gd(3+) enables cell nucleus molecular imaging of prostate cancer cells: the last 600 nm.
    Heckl S; Debus J; Jenne J; Pipkorn R; Waldeck W; Spring H; Rastert R; von der Lieth CW; Braun K
    Cancer Res; 2002 Dec; 62(23):7018-24. PubMed ID: 12460922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras.
    Tian X; Chakrabarti A; Amirkhanov NV; Aruva MR; Zhang K; Mathew B; Cardi C; Qin W; Sauter ER; Thakur ML; Wickstrom E
    Ann N Y Acad Sci; 2005 Nov; 1059():106-44. PubMed ID: 16382049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
    Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
    Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart-specific inhibition of protooncogene c-myc attenuates cold-induced cardiac hypertrophy.
    Bello Roufai M; Li H; Sun Z
    Gene Ther; 2007 Oct; 14(19):1406-16. PubMed ID: 17637797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy.
    Ranney D; Antich P; Dadey E; Mason R; Kulkarni P; Singh O; Chen H; Constantanescu A; Parkey R
    J Control Release; 2005 Dec; 109(1-3):222-35. PubMed ID: 16290245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
    Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
    IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ILK as a potential marker gene to ascertain specific adenocarcinoma cell mRNA isolation from frozen prostate biopsy tissue sections.
    Kieffer N; Schmitz M; Plançon S; Margue C; Huselstein F; Grignard G; Dippel W; Nathan M; Giacchi S; Scheiden R
    Int J Oncol; 2005 Jun; 26(6):1549-58. PubMed ID: 15870868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy.
    Kiessling F; Huber PE; Grobholz R; Heilmann M; Meding J; Lichy MP; Fink C; Krix M; Peschke P; Schlemmer HP
    Invest Radiol; 2004 Jan; 39(1):34-44. PubMed ID: 14701987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic, functional, and metabolic magnetic resonance imaging-guided prostate biopsy in a patient with prior negative transrectal ultrasound-guided biopsies and persistently elevated prostate-specific antigen levels.
    Lichy MP; Anastasiadis AG; Aschoff P; Sotlar K; Eschmann SM; Pfannenberg C; Stenzl A; Claussen CD; Schlemmer HP
    Urology; 2007 Jun; 69(6):1208.e5-8. PubMed ID: 17572221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.
    Garcia GE; Wisniewski HG; Lucia MS; Arevalo N; Slaga TJ; Kraft SL; Strange R; Kumar AP
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):980-8. PubMed ID: 16467113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer.
    Hasumi M; Suzuki K; Taketomi A; Matsui H; Yamamoto T; Ito K; Kurokawa K; Aoki J; Endo K; Yamanaka H
    Anticancer Res; 2003; 23(5b):4223-7. PubMed ID: 14666629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
    Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
    Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
    Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.